{"id":"https://openalex.org/W72388327","doi":null,"title":"[Place of fibrates for the treatment of patients with atherogenic dyslipidemia].","display_name":"[Place of fibrates for the treatment of patients with atherogenic dyslipidemia].","publication_year":2009,"publication_date":"2009-10-01","ids":{"openalex":"https://openalex.org/W72388327","mag":"72388327","pmid":"https://pubmed.ncbi.nlm.nih.gov/19911665"},"language":"fr","primary_location":{"id":"pmid:19911665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19911665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://orbi.uliege.be/handle/2268/31583","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033637905","display_name":"Jean Ducobu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130929987","display_name":"University of Mons","ror":"https://ror.org/02qnnz951","country_code":"BE","type":"education","lineage":["https://openalex.org/I130929987"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J Ducobu","raw_affiliation_strings":["Service de Universit\u00e9 Mons Hainaut, Belgique. jducobu@skynet.be"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Universit\u00e9 Mons Hainaut, Belgique. jducobu@skynet.be","institution_ids":["https://openalex.org/I130929987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A J Scheen","raw_affiliation_strings":["Universit\u00e9 de Li\u00e8ge - ULi\u00e8ge > D\u00e9partement des sciences cliniques > Diab\u00e9tologie, nutrition et maladie m\u00e9taboliques - M\u00e9decine interne g\u00e9n\u00e9rale >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Li\u00e8ge - ULi\u00e8ge > D\u00e9partement des sciences cliniques > Diab\u00e9tologie, nutrition et maladie m\u00e9taboliques - M\u00e9decine interne g\u00e9n\u00e9rale >","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010845000","display_name":"P. Legat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130929987","display_name":"University of Mons","ror":"https://ror.org/02qnnz951","country_code":"BE","type":"education","lineage":["https://openalex.org/I130929987"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P Legat","raw_affiliation_strings":["Universite de Mons"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite de Mons","institution_ids":["https://openalex.org/I130929987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055188417","display_name":"Guy De Backer","orcid":"https://orcid.org/0000-0002-1660-1623","observed_orcids":["https://orcid.org/0000-0002-1660-1623"]},"institutions":[{"id":"https://openalex.org/I130929987","display_name":"University of Mons","ror":"https://ror.org/02qnnz951","country_code":"BE","type":"education","lineage":["https://openalex.org/I130929987"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"G De Backer","raw_affiliation_strings":["Universite de Mons"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite de Mons","institution_ids":["https://openalex.org/I130929987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109345483","display_name":"L. Van Gaal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"L Van Gaal","raw_affiliation_strings":["Antwerp University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antwerp University Hospital","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076989487","display_name":"Brigitte Velkeniers","orcid":"https://orcid.org/0000-0001-8577-9698","observed_orcids":["https://orcid.org/0000-0001-8577-9698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Velkeniers","raw_affiliation_strings":["Internal Medicine Specializations"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine Specializations","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082063059","display_name":"Jan Kartounian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kartounian","raw_affiliation_strings":["General Practitioners and end-of-life-care"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Practitioners and end-of-life-care","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111380701","display_name":"Murielle Maes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M Maes","raw_affiliation_strings":[", KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022085199","display_name":"Michel Paul Hermans","orcid":"https://orcid.org/0000-0002-1647-9031","observed_orcids":["https://orcid.org/0000-0002-1647-9031","https://orcid.org/0000-0002-1189-2265"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hermans","raw_affiliation_strings":["Katholieke Universiteit Brussel - KUB > E n d o c r i n o l o g i e   e t   N u t r i t i o n , >  >  >"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholieke Universiteit Brussel - KUB > E n d o c r i n o l o g i e   e t   N u t r i t i o n , >  >  >","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00755446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"64","issue":"10","first_page":"512","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atherogenic-dyslipidemia","display_name":"atherogenic dyslipidemia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9340000152587891},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.9419999718666077},{"id":"https://openalex.org/keywords/statin-fibrate-combination-therapy","display_name":"statin-fibrate combination therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7310000061988831},{"id":"https://openalex.org/keywords/small-dense-ldl","display_name":"small dense LDL","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/low-hdl-cholesterol","display_name":"low HDL cholesterol","score":0.9340000152587891},{"id":"https://openalex.org/keywords/residual-cardiovascular-risk","display_name":"residual cardiovascular risk","score":0.7509999871253967},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5609999895095825},{"id":"https://openalex.org/keywords/thrombus-formation","display_name":"thrombus formation","score":0.9319999814033508},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.875},{"id":"https://openalex.org/keywords/accord-trial","display_name":"ACCORD trial","score":0.8450000286102295},{"id":"https://openalex.org/keywords/statin-adverse-effects","display_name":"statin adverse effects","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9658692479133606},{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.8997668027877808},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8306859731674194},{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.7897323369979858},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.7602748870849609},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7324717044830322},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6905440092086792},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5250924825668335},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.49269893765449524},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.49061813950538635},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.46652254462242126},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4238974452018738},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.23675328493118286}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002995","descriptor_name":"Clofibric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:19911665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19911665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"English Abstract"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/31583","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/31583","pdf_url":"https://orbi.uliege.be/handle/2268/31583","source":{"id":"https://openalex.org/S4306400651","display_name":"Open Repository and Bibliography (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revue M\u00e9dicale de Li\u00e8ge, 64 (10), 512-8 (2009)","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:63114","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/place-of-fibrates-for-the-treatment-of-patients-with-atherogenic-dyslipidemia(e978884e-34b5-44af-972b-6709c26e2b3b).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"mag:72388327","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19911665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:orbi.ulg.ac.be:2268/31583","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/31583","pdf_url":"https://orbi.uliege.be/handle/2268/31583","source":{"id":"https://openalex.org/S4306400651","display_name":"Open Repository and Bibliography (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revue M\u00e9dicale de Li\u00e8ge, 64 (10), 512-8 (2009)","raw_type":"http://purl.org/coar/resource_type/c_6501"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W72388327.pdf","grobid_xml":"https://content.openalex.org/works/W72388327.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W60693599","https://openalex.org/W74340591","https://openalex.org/W238863385","https://openalex.org/W1964607854","https://openalex.org/W1971175832","https://openalex.org/W1975018096","https://openalex.org/W1976428272","https://openalex.org/W2005965794","https://openalex.org/W2010525799","https://openalex.org/W2029684996","https://openalex.org/W2086922191","https://openalex.org/W2102312517","https://openalex.org/W2102906564","https://openalex.org/W2103714496","https://openalex.org/W2117092539","https://openalex.org/W2118860915","https://openalex.org/W2137489898","https://openalex.org/W2154067841","https://openalex.org/W2198678228","https://openalex.org/W2313240267","https://openalex.org/W2328529137","https://openalex.org/W2341665659","https://openalex.org/W2400712338","https://openalex.org/W2407931958","https://openalex.org/W2416875811"],"related_works":["https://openalex.org/W2029684996","https://openalex.org/W7100657304","https://openalex.org/W7096384923","https://openalex.org/W2125763086","https://openalex.org/W4415654139","https://openalex.org/W2107904682","https://openalex.org/W2384361126","https://openalex.org/W1991786268","https://openalex.org/W2015400688","https://openalex.org/W2076095448"],"abstract_inverted_index":{"The":[0,175],"demography":[1],"of":[2,15,34,36,118,122,132,154,169,183,186,194],"dyslipidemia":[3,11],"has":[4,161],"changed":[5],"towards":[6],"a":[7,59,128,166],"more":[8,129],"complex":[9],"atherogenic":[10,21],"involving":[12],"increased":[13,32],"levels":[14,33],"LDL":[16],"cholesterol,":[17,29,89],"in":[18,63],"particular":[19,64],"highly":[20],"small":[22],"dense":[23],"particles,":[24],"hypertriglyceridemia":[25],"and":[26,39,50,86,94,109,135,156,192],"low":[27,74,167],"HDL":[28,75,88],"together":[30],"with":[31,58,67,99,124,144,151,159,188,196],"markers":[35,137],"inflammation,":[37,92],"thrombogenesis":[38,93],"endothelial":[40,95],"dysfunction.":[41,96],"Statins":[42],"were":[43],"shown":[44,81,127,163],"to":[45,82,105,164],"significantly":[46,150],"lower":[47],"cardiovascular":[48,107],"morbidity":[49,108,191],"mortality,":[51],"but":[52],"treated":[53],"patients":[54,195],"are":[55],"still":[56],"left":[57],"high":[60],"residual":[61],"risk,":[62],"for":[65],"those":[66,117],"metabolic":[68],"syndrome,":[69],"type":[70,197],"2":[71,198],"diabetes,":[72],"or":[73,172],"cholesterol":[76],"levels.":[77],"Fibrates":[78],"have":[79,101,126,165],"been":[80,162],"reduce":[83,106],"plasma":[84],"triglycerides":[85],"increase":[87],"while":[90],"improving":[91],"Clinical":[97],"trials":[98,121],"fibrates":[100,125],"demonstrated":[102],"their":[103],"potential":[104],"mortality":[110,193],"too,":[111],"often":[112],"through":[113],"other":[114],"mechanisms":[115],"than":[116,138],"statins.":[119],"Combination":[120],"statins":[123,160,189],"complete":[130],"improvement":[131],"lipid":[133],"profile":[134],"risk":[136,168],"each":[139],"class":[140],"separately.":[141],"In":[142],"contrast":[143],"gemfibrozil,":[145],"fenofibrate":[146,187],"does":[147],"not":[148],"interact":[149],"the":[152,184],"pharmacokinetics":[153],"statins,":[155],"its":[157],"combination":[158,185],"muscular":[170],"side-effects":[171],"liver":[173],"toxicity.":[174],"ACCORD":[176],"outcome":[177],"trial":[178],"is":[179],"exploring":[180],"possible":[181],"benefits":[182],"on":[190],"diabetes.":[199]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
